Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $48
Morgan Stanley analyst Jon Demchick maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target from $54 to $48.
Truist Securities Maintains Buy on NuVasive, Lowers Price Target to $58
Truist Securities analyst Richard Newitter maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $63 to $58.
Needham Maintains Buy on NuVasive, Lowers Price Target to $53
Needham analyst David Saxon maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $67 to $53.
Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday
GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday.
Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $54
Morgan Stanley analyst Drew Ranieri maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target from $62 to $54.
NuVasive Earnings Perspective: Return On Invested Capital
According to Benzinga Pro, during Q1, NuVasive (NASDAQ:NUVA) earned $19.20 million, a 152.27% increase from the preceding quarter. NuVasive's sales decreased to $290.76 million, a 3.75% change since Q4.
Needham Maintains Buy on NuVasive, Raises Price Target to $67
Needham analyst David Saxon maintains NuVasive (NASDAQ:NUVA) with a Buy and raises the price target from $64 to $67.